生物製剤安全性試験市場：製品、試験タイプ、用途、エンドユーザー別-2023～2030年の世界予測

生物製剤安全性試験の世界市場は大きく成長すると予測され、2023年にはCAGR 14.65%で56億2,385万米ドルが予測され、2030年には驚異的な147億245万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の生物製剤安全性試験市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.生物製剤安全性試験の世界市場規模および予測は？

2.予測期間中、世界の生物製剤安全性試験市場を形成するCOVID-19の阻害要因と影響は？

3.生物製剤安全性試験の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.生物製剤安全性試験の世界市場における競争戦略は？

5.生物製剤安全性試験の世界市場における技術動向と規制の枠組みは？

6.生物製剤安全性試験の世界市場における主要ベンダーの市場シェアは？

7.生物製剤安全性試験の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臨床試験活動における安全性の監視と試験の急激なニーズ
    • 医薬品リコール数の増加と生物製剤製品の安全性に関する政府の取り組みと基準
    • 医療機器の生産・貿易とその品質評価の増加
  • 抑制要因
    • 医薬品開発のための安全性試験には高額な費用が必要
  • 機会
    • 生物学的安全性試験における技術革新と進歩
    • 安全性を向上させた組換えタンパク質および細胞および遺伝子治療のための研究を拡大
  • 課題
    • 正確な試験を実行するための熟練した専門家が不足している
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 生物製剤安全性試験市場：製品別

• イントロダクション
• 消耗品
• 装置
• サービス

第7章 生物製剤安全性試験市場：試験タイプ別

• イントロダクション
• バイオバーデン試験
• エンドトキシン検査
• マイコプラズマ検査
• 残留宿主細胞タンパク質およびDNA検出検査
• 無菌試験
• ウイルスの安全性試験

第8章 生物製剤安全性試験市場：用途別

• イントロダクション
• 血液および血液関連製品の開発
• 細胞および遺伝子治療製品の開発
• モノクローナル抗体の開発
• ワクチンと治療薬の開発

第9章 生物製剤安全性試験市場：エンドユーザー別

• イントロダクション
• 学術研究機関
• 調査受託機関・製造受託機関
• 製薬およびバイオテクノロジー企業

第10章 南北アメリカの生物製剤安全性試験市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の生物製剤安全性試験市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの生物製剤安全性試験市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別
  • 合併・買収
  • 契約、コラボレーション、パートナーシップ
  • 新製品発売と機能強化
  • 投資、資金調達
  • 受賞・表彰・拡大

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. BIOLOGICS SAFETY TESTING MARKET RESEARCH PROCESS
• FIGURE 2. BIOLOGICS SAFETY TESTING MARKET SIZE, 2022 VS 2030
• FIGURE 3. BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
• FIGURE 6. BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. BIOLOGICS SAFETY TESTING MARKET DYNAMICS
• FIGURE 10. BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BIOLOGICS SAFETY TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 9. BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BIOLOGICS SAFETY TESTING MARKET SIZE, BY MYCOPLASMA TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BIOLOGICS SAFETY TESTING MARKET SIZE, BY VIRUS SAFETY TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD & BLOOD-RELATED PRODUCTS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. BIOLOGICS SAFETY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODIES DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. BIOLOGICS SAFETY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. BIOLOGICS SAFETY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 193. BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 194. BIOLOGICS SAFETY TESTING MARKET LICENSE & PRICING

The Global Biologics Safety Testing Market is forecasted to grow significantly, with a projected USD 5,623.85 million in 2023 at a CAGR of 14.65% and expected to reach a staggering USD 14,702.45 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biologics Safety Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biologics Safety Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumable, Instruments, and Services. The Instruments commanded largest market share of 48.75% in 2022, followed by Services.

Based on Test Type, market is studied across Bioburden Tests, Endotoxin Tests, Mycoplasma Tests, Residual Host-Cell Proteins & DNA Detection Tests, Sterility Tests, and Virus Safety Tests. The Bioburden Tests commanded largest market share of 22.77% in 2022, followed by Endotoxin Tests.

Based on Application, market is studied across Blood & Blood-Related Products Development, Cellular & Gene Therapy Products Development, Monoclonal Antibodies Development, and Vaccine & Therapeutics Development. The Vaccine & Therapeutics Development commanded largest market share of 28.63% in 2022, followed by Blood & Blood-Related Products Development.

Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organization/ Contract Manufacturing Organization, and Pharmaceutical & Biotechnology Companies. The Contract Research Organization/ Contract Manufacturing Organization commanded largest market share of 41.24% in 2022, followed by Pharmaceutical & Biotechnology Companies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.45% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biologics Safety Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biologics Safety Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Safety Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Safety Testing Market?

4. What is the competitive strategic window for opportunities in the Global Biologics Safety Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Biologics Safety Testing Market?

6. What is the market share of the leading vendors in the Global Biologics Safety Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Biologics Safety Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Biologics Safety Testing Market, by Product, 2022 vs 2030
• 4.3. Biologics Safety Testing Market, by Test Type, 2022 vs 2030
• 4.4. Biologics Safety Testing Market, by Application, 2022 vs 2030
• 4.5. Biologics Safety Testing Market, by End-User, 2022 vs 2030
• 4.6. Biologics Safety Testing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Exponential need for safety monitoring & testing in clinical trials activities
    • 5.1.1.2. Growing number of drug recalls and government initiatives and standards for biologics product safety
    • 5.1.1.3. Increasing production and trade of medical devices and their quality evaluation
  • 5.1.2. Restraints
    • 5.1.2.1. High-cost requirement of safety testing for the development of drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovation and advancements in biologic safety testing
    • 5.1.3.2. Expanding research for improved safety recombinant protein and cell & gene therapy
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals to perform accurate testing
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Biologics Safety Testing Market, by Product

• 6.1. Introduction
• 6.2. Consumable
• 6.3. Instruments
• 6.4. Services

7. Biologics Safety Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Bioburden Tests
• 7.3. Endotoxin Tests
• 7.4. Mycoplasma Tests
• 7.5. Residual Host-Cell Proteins & DNA Detection Tests
• 7.6. Sterility Tests
• 7.7. Virus Safety Tests

8. Biologics Safety Testing Market, by Application

• 8.1. Introduction
• 8.2. Blood & Blood-Related Products Development
• 8.3. Cellular & Gene Therapy Products Development
• 8.4. Monoclonal Antibodies Development
• 8.5. Vaccine & Therapeutics Development

9. Biologics Safety Testing Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Contract Research Organization/ Contract Manufacturing Organization
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Biologics Safety Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biologics Safety Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biologics Safety Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player
  • 13.3.1. Merger & Acquisition
    • 13.3.1.1. Solvias acquires Cergentis to boost biologics testing capabilities.
    • 13.3.1.2. Charles River to acquire Cognate BioServices for USD 875 Million.
  • 13.3.2. Agreement, Collaboration, & Partnership
    • 13.3.2.1. Oxford Nanopore and Pathoquest Announce the First Steps in a Strategic Collaboration to Bring the First Gmp-Accredited, Nanopore-Based Biologics Genetic Characterisation Test to Market.
    • 13.3.2.2. Nykode Therapeutics and Richter-Helm BioLogics Announce Partnership.
  • 13.3.3. New Product Launch & Enhancement
    • 13.3.3.1. Identifysensors Biologics Partners with Jabil Healthcare to Manufacture Digital Diagnostic Platform.
  • 13.3.4. Investment & Funding
    • 13.3.4.1. Why Teva is Investing Over One Billion Dollars in Biologics in Europe.
  • 13.3.5. Award, Recognition, & Expansion
    • 13.3.5.1. Clean Cells Launches Biopharmaceutical Quality Control Facility.
    • 13.3.5.2. Abzena Opens a New Biologics Testing Lab.

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing